Table 1: Reimbursement recommendations by the CADTH Common Drug Review and listing decisions by 4 provincial drug plans for medicine-indication pairs

Health technology assessment agency or provincial payer	Reimbursement recommendation or listing decision; % of medicine-indication pairs (95% CI)
Health technology assessment agency or provincial payer	Positive*	Negative*
CADTH (n = 110)	52.7 (43.5-61.8)	47.3 (38.2-56.5)
Alberta Health (n = 95)	58.9 (48.9-68.3)	41.1 (31.7-51.1)
British Columbia Pharmacare (n = 106)	54.7 (45.2-63.9)	45.3 (36.1-54.8)
Ontario Drug Benefit Plan (n = 104)	68.3 (58.8-76.4)	31.7 (23.6-41.2)
INESSS (Quebec) (n = 102)	69.6 (60.1-77.7)	30.4 (22.3-39.9)

Note: CI = confidence interval, INESSS = Institut national d'excellence en santé et en services sociaux.

*A recommendation/decision to reimburse the medicine, even if there were restrictions, was considered positive and a recommendation/decision to not reimburse was considered negative.